Precigen, Inc. (PGEN) stock analysis

PGEN · Precigen, Inc.

Latest recorded price: USD 4.30

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth -54.6%, free cash flow margin -927.6%, ROIC -136.0%. The model flags 2 risk signals for this company (2 high severity).

Similar companies in Healthcare